KLK3 and benign prostatic hyperplasia: However, PSA testing presents high false-positive rates that contribute to overdiagnosis, unnecessary biopsies, and overtreatment because it is also associated with other benign diseases, such as benign prostatic hyperplasia (BPH) or prostatitis (Loeb et al., 2014; Ferrer-Batallé et al., 2017).